Skip to main content
  • Loading metrics

OSBPL10, RXRA and lipid metabolism confer African-ancestry protection against dengue haemorrhagic fever in admixed Cubans

  • Beatriz Sierra ,

    Contributed equally to this work with: Beatriz Sierra, Petr Triska (BS); (LP)

    Affiliation Virology Department, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kourí Institute of Tropical Medicine (IPK),Havana, Cuba

  • Petr Triska ,

    Contributed equally to this work with: Beatriz Sierra, Petr Triska

    Affiliations i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal

  • Pedro Soares,

    Affiliation Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal

  • Gissel Garcia,

    Affiliation Virology Department, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kourí Institute of Tropical Medicine (IPK),Havana, Cuba

  • Ana B. Perez,

    Affiliation Virology Department, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kourí Institute of Tropical Medicine (IPK),Havana, Cuba

  • Eglys Aguirre,

    Affiliation Virology Department, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kourí Institute of Tropical Medicine (IPK),Havana, Cuba

  • Marisa Oliveira,

    Affiliations i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal, Eukaryote Genotyping Platform, Genopole Pasteur Institute, Paris, France, Functional Genetics of Infectious Diseases Unit, Pasteur Institute, Paris, France

  • Bruno Cavadas,

    Affiliations i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal

  • Béatrice Regnault,

    Affiliation Eukaryote Genotyping Platform, Genopole Pasteur Institute, Paris, France

  • Mayling Alvarez,

    Affiliation Virology Department, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kourí Institute of Tropical Medicine (IPK),Havana, Cuba

  • Didye Ruiz,

    Affiliation Virology Department, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kourí Institute of Tropical Medicine (IPK),Havana, Cuba

  • David C. Samuels,

    Affiliation Vanderbilt Genetics Institute, Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, United States of America

  • Anavaj Sakuntabhai,

    Affiliation Functional Genetics of Infectious Diseases Unit, Pasteur Institute, Paris, France

  • Luisa Pereira , (BS); (LP)

    Affiliations i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal, Faculdade de Medicina da Universidade do Porto (FMUP), Porto, Portugal

  • Maria G. Guzman

    Affiliation Virology Department, PAHO/WHO Collaborating Center for the Study of Dengue and its Vector, Pedro Kourí Institute of Tropical Medicine (IPK),Havana, Cuba


Ethnic groups can display differential genetic susceptibility to infectious diseases. The arthropod-born viral dengue disease is one such disease, with empirical and limited genetic evidence showing that African ancestry may be protective against the haemorrhagic phenotype. Global ancestry analysis based on high-throughput genotyping in admixed populations can be used to test this hypothesis, while admixture mapping can map candidate protective genes. A Cuban dengue fever cohort was genotyped using a 2.5 million SNP chip. Global ancestry was ascertained through ADMIXTURE and used in a fine-matched corrected association study, while local ancestry was inferred by the RFMix algorithm. The expression of candidate genes was evaluated by RT-PCR in a Cuban dengue patient cohort and gene set enrichment analysis was performed in a Thai dengue transcriptome. OSBPL10 and RXRA candidate genes were identified, with most significant SNPs placed in inferred weak enhancers, promoters and lncRNAs. OSBPL10 had significantly lower expression in Africans than Europeans, while for RXRA several SNPs may differentially regulate its transcription between Africans and Europeans. Their expression was confirmed to change through dengue disease progression in Cuban patients and to vary with disease severity in a Thai transcriptome dataset. These genes interact in the LXR/RXR activation pathway that integrates lipid metabolism and immune functions, being a key player in dengue virus entrance into cells, its replication therein and in cytokine production. Knockdown of OSBPL10 expression in THP-1 cells by two shRNAs followed by DENV2 infection tests led to a significant reduction in DENV replication, being a direct functional proof that the lower OSBPL10 expression profile in Africans protects this ancestry against dengue disease.

Author summary

Dengue is a concern of worldwide health authorities given the increase on virus and vector dispersions. So far only one traditional GWAS survey has been performed in Vietnamese children. This disease is also epidemic in tropical and subtropical regions of the Americas, where most populations descend from a dynamic admixture between African, European and Native American backgrounds. Empirical evidence claimed that African descent was protective against dengue haemorrhagic phenotype in the Cuban population, and this study is the first to apply admixture mapping to identify candidate genes that confer African protection. We also present evidence that two candidate genes, OSBPL10 and RXRA, are differentially expressed along dengue disease progression in Cuban patients and in a Thai dengue transcriptome dataset, and directly show that knockdown of OSBPL10 gene expression leads to a significant reduction in DENV2 replication. A very important overall result of our work is that it provides a unifying framework for many genes that have been said to be protective in dengue. Our evidence places the LXR/RXR activation pathway at the center of natural dengue protection, and supports pursuing therapeutic techniques involving synthetic ligands of nuclear receptor genes or kinases inhibitors that interact with proteins involved in lipid metabolism.


Dengue is an emerging arthropod-born viral disease caused by the infection with any of the four dengue viruses (DENV-1 to 4). The virus is transmitted to humans by Aedes aegypti and Aedes albopictus mosquitoes. Morbidity and mortality associated with severe dengue infection render this disease a major increasing public health problem throughout tropical and subtropical regions. Dengue illness is also attracting awareness in Europe and in the United States as climate change and globalisation enlarge the geographic dispersion of the vector and the viruses [1]. A dengue infection can evolve from a subclinical infection, a relatively mild, self-limited infection known as dengue fever (DF), to the severe disease called dengue haemorrhagic fever (DHF), which may evolve to a life-threatening hypovolemic shock (dengue shock syndrome, DSS [2]). But only a small proportion of antibody-positive individuals develops DHF/DSS, while the vast majority suffers an asymptomatic infection or the mild disease. This differential susceptibility to disease severity indicates that besides immune factors, the host genetics may influence the infection outcome, acting in a complex interplay with viral and environmental factors. Diverse single nucleotide polymorphisms (SNPs) in genes such as HLA-I, HLA-II, TNF-α, IL-10, TGF-β1, FcγRIIa, VDR, CD209 and OAS have been associated with symptomatic dengue or considered protective against the disease, in Asian and Latin American populations [3]. Also, MICA and MICB genes have been associated with susceptibility to dengue in Cuba [4], partially overlapping previous results reported in the only genome-wide association study (GWAS) performed so far in Vietnamese children, and showing significant association of MICB and PLCE1 genes with DSS [5].

Evidence supporting the impact of human genetic factors on infection outcome also comes from differences between ethnic groups in developing severe DHF/DSS symptoms [6]. As early as in 1906, it was reported that Cuban dark-skinned individuals showed a remarkable resistance against dengue disease compared with light-skinned individuals [7]. This early observation was confirmed during the 1981 Cuban DHF/DSS epidemic of DENV-2 when ethnicity was recognized for the first time as a possible host risk factor, and confirmed afterwards in several other dengue Cuban outbreaks [8]. The low occurrence of dengue disease in Haitians [9] and in African populations [10] adds further support for this ancestry influence. A genetic characterization of 30 ancestry informative markers conducted in the Colombian population [11] confirmed the protective effect of African ancestry against severe dengue outcomes (odds ratios, ORs in 0.963–0.971 interval).

Till recently, population structure as occurs in admixed populations was a major confounding factor, requiring strategies for correction of the association p-values [12]. But admixed populations are a great advantage in cases of differential ancestry-conferred susceptibility/resistance to a disease through the use of admixture mapping [13]. The rationale of admixture mapping is that the ancestry blocks will be distributed at random across the genome, reflecting the admixture proportions of the parental ancestries, except in candidate gene locations where statistically significantly different proportions for the ancestry with higher disease levels will be observed in cases versus controls. It has been shown that this test is statistically more powerful than traditional GWAS [14]: around 250 samples can provide a 60% power to detect a two-fold risk due to ancestry, compared to the thousands of samples required in GWAS. In fact, because of the recentness of admixture, the typical ancestry blocks are significantly larger than haplotype blocks, thus lowering the multiple testing burden. This strategy has been successfully applied in African-Americans and Latin-Americans, in association with various diseases, such as asthma [15] and type 2 diabetes [16].

Cuba is advantageous for studies of ancestry-conferred DHF susceptibility/protection. The current Cuban population is mainly derived from the mix of two well-defined ancestral populations: European colonizers, who began to arrive in 1492 from the Iberian Peninsula, followed by other countries; and enslaved Africans, arriving in the 16th century, mainly from West Africa. The contribution of the first aboriginal Cuban inhabitants, almost totally exterminated during the Spanish conquest, is almost negligible [17]. The Western and Eastern sides of the island show differences in historic settlement, with European descendants concentrating in the capital [17]. DENV experience has also been different among them. After an absence of 40 years, DENV1 was reported in 1977 and transmitted to nearly one-half of the Cuban population. Four years later, DENV2 (Asian origin) infected approximately 25% of the population, and a large DHF/DSS epidemic occurred. In 1997, another Asian DENV2 virus entered the country, producing a local epidemic in the municipality of Santiago de Cuba. In 2001, DENV3 (Asian genotype), was detected in Havana city [18]. In 2006, the circulation of DENV4 was reported in Havana, while DENV3 affected Guantanamo [19].

We conducted a GWAS of 2.5 million SNPs in 274 Cubans, including patients (DF and DHF) of the 2006 dengue epidemic, from Havana (west) and Guantanamo (east) cities, and in geographically matched asymptomatic individuals and population controls. The high level of admixture in Cuba enabled us to apply the first admixture mapping, thus facilitating the identification of candidate markers ethnically associated with dengue infection. Firstly, we conducted a global admixture analysis which allowed us to confirm the statistically significant decrease of African ancestry in the DHF cohort and to fine tune the association analysis in the admixed Cubans (cases and controls were paired to not differ more than 2% in African ancestry), whose statistical burden is 2.6x10-8. Secondly, we performed a local ancestry assignment along chromosomes which identified the precise regions (and genes) where the African ancestry was significantly higher in asymptomatic compared with DHF (above 3SD threshold in the difference in African ancestry between controls-cases). The fine-tuned association analysis can identify a few SNPs (located in a small chromosomal region) that confer reasonable individual risk/protection; the local ancestry assignment can identify ancestry-related blocks (medium to big chromosomal regions, depending on the time since admixture) containing SNPs conferring low-medium risk/protection, which would escape the association test. We also performed a functional test consisting in knocking down the expression of one candidate gene by shRNA, followed by DENV infection assays.


Global ancestry influence in dengue infection outcome

The genome-wide Cuban screening confirmed that all individuals in this study have a mixed ancestral composition. The main ancestry backgrounds (Fig 1A for K = 4) derive from Africa (represented by the blue colour) and Europe (red), but the range follows the entire spectrum of admixture, from nearly 0% African and 90% European to the inverse ratio, while the remaining 10% are from Native American (yellow) and East Asian (orange) influences. Comparing the population control groups from Havana and Guantanamo (HC and GC) as references for the two geographical regions, the average proportions of the African component are statistically different (25.2% and 35.3%, respectively; two-tailed Wilcoxon rank-sum test p = 1.43x10-3), identical to published values [20]. The Native American component was 6.5% in Havana and 13.5% in Guantanamo, values statistically significantly different (p = 1x10-6); while the East Asian component was of 1.9% and 0.7% respectively (p = 0.224). A finer description of Cuban ancestry is presented in Supplementary section 1.2 (Figs A-C in S1 Text). This includes confirmation that, despite the statistical differences in the African/European components between Havana and Guantanamo, the sub-structures within those two components in the two cities are identical, not favouring differential migration events into the two parts of the island (Figs D-E in S1 Text).

Fig 1. The global ancestry in Cuba and its influence on susceptibility to dengue.

(A) ADMIXTURE results for four ancestral populations (blue component represents the European ancestry, red the African, yellow the Native American and Orange the East Asian). HC: Havana controls, HA: Havana individuals with asymptomatic infection, HH: Havana DHF cases, HF: Havana DF cases, GC: Guantanamo controls, GA: Guantanamo individuals with asymptomatic infection, GH: Guantanamo DHF cases, GF: Guantanamo DF cases. (B) Box plots for the African ancestry in the Cuban groups: controls; individuals with asymptomatic infection; DF (dengue fever); DHF (dengue haemorrhagic fever). The boxes represent the interquartile range and the whiskers are the 5% and 95% quartiles. The significant p-values for the two-tailed Wilcoxon rank-sum test between pairs of groups are displayed; non-significant ones are not displayed.

Focusing on the global ancestry among the Cuban cohorts (Fig 1B), the average African ancestry is significantly lower in DHF (22.9%) when compared with DF, controls and especially asymptomatic groups (30.6%, p-value = 0.025; 30.0%, p-value = 0.041; 34.7%, p-value = 0.013, respectively). These results confirmed that African ancestry is protective against DHF phenotype in Cuba, and the odds ratios are very similar to the ones reported in Colombia [11] (Table 1). Nevertheless, the evidence of ancestry influence in dengue was not so straightforward when the samples were divided according to the city of origin: in Havana, the African ancestry is even more significantly lower in DHF (10.3%) compared with DF, controls and especially asymptomatic (24.4%, p-value = 0.009; 25.2%, p-value = 0.015; 33.0%, p-value = 0.002, respectively) and OR even more protective (Table 1); while in Guantanamo, the African averages are statistically identical between all groups (35.3% in controls, 38.1% asymptomatic, 36.4% DHF and 36.0% DF). This complex relation was confirmed by an iterative model (Fig F in S1 Text). Our data show that there is an African protection conferred against DHF in Cuba, but other currently unknown confounding factors render it a complex relation, even in such a geographical restricted scenario as Cuba.

Table 1. Odds ratios of the African ancestry influence in DHF phenotype when compared to asymptomatic subjects, in Cuba in general, only Havana city and in Colombia.

Fine-matched corrected population structure followed by association evaluation

The fine-matched corrected association tests (Tables C-E in S1 Text) identified the lowest p-values (10−6–10−7) in the DHF comparison (HCG–haemorrhagic comparison group) for six highly linked (Fig 2A; Table I and Figs N-P in S1 Text) SNPs extending for 8,370 bps in chromosome 3, in a region containing the OSBPL10 (oxysterol binding protein-like 10) gene (Fig 2B). These p-values are close to the significant cutoff of 10−8. OSBPL10 protein is involved in lipid transport and steroid metabolism. Curiously, the most frequent haplotypes in African and European populations consist totally of the alternative alleles for all six SNPs, and attain frequencies higher than 50% in each continent (Fig 2C). The odds ratio calculated in DHF is 0.25 [95% CI 0.13–0.47] for the African haplotype (Table 2).

Fig 2. The relevant region on chromosome 3 containing the OSBPL10 gene

(A) Manhattan plot for the association analysis in the 54 fine-matched population structure corrected Cuban pairs of asymptomatic/control versus DHF subjects. (B) The region on chromosome 3, with the haplotype defined by the six significantly associated SNPs indicated by the red box. Genes on the forward sense are indicated in blue; genes on the reverse sense are indicated in light brown. (C) Worldwide frequency of the African (blue), European (red) and other (grey) OSBPL10 haplotypes for populations of the 1000 Genomes project, and also for asymptomatic/control and DHF in Cuba. (D) mRNA expression for homozygous genotypes for African and European OSBPL10 haplotypes in the 1000 Genomes project transcriptome information.

Table 2. Odds ratios of the African OSBPL10 haplotype and RXRA alleles in DHF when compared with asymptomatic/control and tests (identified by Y) where statistical significant evidence was detected for each gene.

By using the 1000 Genomes transcriptome [21], we confirmed that the homozygous individuals for the OBSPL10 African haplotype have a significantly reduced (by half) expression (mean value = 0.145) when compared with the homozygous for the European haplotype (mean value = 0.257; p<0.001; Fig 2D). This indicates that the haplotype affects mRNA expression. We further ascertained that these non-coding SNPs are not located in the inferred promoter, but they can be related with weaker enhancer regions and are recognised by many transcription factors, including STAT and RXRA (Fig Q in S1 Text). Besides the haplotype region, the segment immediately 5’ to it (within the gene) has some SNPs with significant p-values in the association test that are also regulatory regions in several cell types (Table O and Fig R in S1 Text). Although there is no current good database to check eQTLs in African populations, we used GTEx despite its highly European-biased dataset (84.3%). The six identified OSBPL10 SNPs are not identified in GTEx as eQTLs, but surveying the eQTLs located on that chromosomal region, there is one with frequency differences between African and European populations (rs7642435, at position 32036787; 1000 Genomes frequency in Africa–A = 0.092, G = 0.908; 1000 Genomes frequency in Europe–A = 0.723, G = 0.277), which presents alternative homozygous genotypes associated with our African/European haplotypes: “African” haplotype with rs7642435_GG and “European” haplotype with rs7642435_AA. As can be confirmed in Fig S in S1 Text, rs7642435_GG has a significant reduction of OSBPL10 expression compared with rs7642435_AA, and this SNP is predicted to have an eQTL effect (posterior probability>0.9) in several tissues: artery (aorta, coronary and tibial), brain (nucleus accumbens and caudate), liver, adrenal gland, pancreas, esophagus (muscularis and gastroesophageal junction), stomach, nerve and cells-transformed fibroblasts. The remaining eQTLs in the region are almost fixed in both African and European populations. Possibly, our haplotype association is identifying the rs7642435 eQTL, although more information on African eQTLs is needed in order to ascertain other possible eQTLs in the OSBPL10 region.

This extended OSBPL10 segment (haplotype and immediate 5’ region) has probably been under positive selection in the African Yoruban population, as inferred in the Haplotter tool based on HapMap dataset (iHS measure; Fig T in S1 Text). The positive selection of OSBPL10 gene was confirmed in Cuban HCG when applying XP-EHH measure (Fig M and Tables M-N in S1 Text). Therefore, it seems that the OSBPL10 haplotype and its 5’ region, although non-coding, bear several expression regulatory SNPs with large frequency differences between Africans and Europeans, probably due to selection events.

Several other SNPs located on genes (mostly one or two SNPs per gene) reached association p-values of 10−5. By checking which SNPs are more frequent in Africa (information from the 1000 Genomes database) and which genes would have differential gene expression between dengue patients and control/convalescent subjects (in the whole blood transcriptome obtained in a Thai dengue dataset [22] and using a linear discriminant analysis effect size method, LEfSe [23], for high-dimensional class comparisons), besides OSBPL10, a few kinases or kinase-related genes are amongst the most significant genes (Fig G in S1 Text): CAMK1D (calcium/calmodulin-dependent protein kinase ID), MAPKAPK5 (mitogen-activated protein kinase-activated protein kinase 5), PIK3AP1 (phosphoinositide-3-kinase adaptor protein 1), SNRK (sucrose nonfermenting related kinase), GNA14 (guanine nucleotide binding protein (G protein), alpha 14) and DAB-1 (dab, reelin signal transducer, homolog 1 (Drosophila)).

The non-African set (Fig H in S1 Text) has more variable and generalized functions, dealing with hemostasis (DOCK10), phospholipid binding (PLEKHM1L), protein serine/threonine kinase activity and ribosomal protein S6 kinase activity (RPS6KA2), protein homodimerization activity and HMG box domain binding (OLIG2), sequence-specific DNA binding transcription factor activity and chromatin binding (TSHZ3).

Fine-matched corrected population structure followed by admixture mapping

The admixture mapping led to the identification of locally enriched African regions across the genome in the asymptomatic/controls (Figs I-K and Tables F-H in S1 Text). One of these regions is located on chromosome 9 (detected at HCG and FCG/fever comparisons), containing the RXRA (retinoid X receptor alpha), COL5A1 (collagen type V alpha 1) and FCN2 (ficolin (collagen/fibrinogen domain containing lectin) 2) genes. We confirmed from the expression data on Thai dengue patients [22] that only RXRA has statistically significant altered expression (Fig L in S1 Text), supporting several lines of evidence linking retinoid receptors with infectious diseases and dengue [24]. Detailed description of other significant regions is presented in supplementary material sections 1.5 and 1.6 (Tables K-L in S1 Text).

We checked the SNPs with significant association p-values in the RXRA-COL5A1 region in the Cuban HCG (Fig 3; Table J in S1 Text), and verified that two locations have higher significant p-values and OR between 0.103–0.436 (Table 2). The most significant p-values are for three intergenic SNPs (rs4262378, rs4424343 and rs3118593) located in inferred enhancers (Table P in S1 Text). The other location is immediately before and in the beginning of RXRA, and contains SNPs rs12339163 and rs62576287 (the latter only exists in Africa with a 9% frequency) placed in poised and weak promoters and weak enhancers. From these various significant SNPs, only rs3118593 is within a promoter and a lncRNA (RP11-473E2.4; Fig 3), and interestingly, according to the GTEx portal, the patterns of expression for RXRA and RP11-473E2·4 genes in the various human tissues are totally opposite, with RXRA being mainly expressed in liver, muscle, skin and whole blood while almost not expressed in brain and testis, and the other way around for RP11-473E2·4 (Figs U-W in S1 Text). The opposite expression pattern between the RXRA and RP11-473E2·4 genes raises the possibility that the lncRNA silences the expression of RXRA. When checking the RXRA mRNA expression for the typical African and European genotypes in those SNPs (based on the 1000 Genomes transcriptome from lymphoblastoid cell lines), no statistical differences were observed (data not presented). We further performed association tests for the whole RXRA-COL5A1 region in the 1000 Genomes transcriptome comparing RXRA high- and low-expression groups within Africans and Europeans. The African test shows that there are 37 significant (at the 1% level) SNPs surrounding RXRA gene, including rs3118593, that are differently frequent between the high- with low-expression groups, and these can be regions for expression regulation of the gene (Fig 3; Table Q in S1 Text). While in Europe, the number of significantly differentiated SNPs is much lower, only six (Fig 3; Table R in S1 Text). A reasonable hypothesis would be that the advantage in Africans is related with a faster control of RXRA expression.

Fig 3. The RXRA-COL5A1 region with the most significant SNPs highlighted.

Map obtained with the LocusZoom tool, using recombination rate information from the Yoruba reference population. The symbols above the rule represent significant SNPs, for the Cuban data (the pink triangles), the African comparison between individuals having low (n = 6; lower than 10 RPKM) and high (n = 8; higher than 20 RPKM) RXRA expression (green circles), the same for European individuals (n = 42 and n = 39, respectively; blue squares).

OSBPL10 and RXRA expression in dengue patients and focused enrichment analysis

The genetic evidence collected in this work, summed up in Table 2, for the involvement of OSBPL10 and RXRA genes in the protection against DHF, led us to check their expression in Cuban patients throughout the infection process (Fig 4). The mRNA expression of RXRA was significantly higher during convalescence (day 30) compared to day 3 (p = 0.027), and also higher than at day 7 after fever onset (not significant). There were no significant differences between days 3 and 7 after fever onset. These results are comparable with the ones for the Thai dataset, where RXRA expression is significantly decreased in DF and DHF cohorts when compared with controls and convalescent, indicating that this gene expression is decreased along the disease course, and only returns to normal values in convalescence. The differences between DF and DHF cohorts did not reach statistical significance, what can be explained by the small sample size.

Fig 4. Gene expression for RXRA and OSBPL10 in Cuban dengue patients along the course of disease

Data is shown for all Cuban patients, Cuban patients with warning signs, and the Thai transcriptome dataset for whole blood. [22]

The mRNA expression of OSBPL10 was significantly increased by day 7 and in convalescence, when compared with day 3 (p<0.001 for both). There is a decrease between day 7 and convalescence, but it is not significant. In Thai, the DHF group has a significantly higher OSBPL10 expression compared with all other groups. Considering both datasets, it seems that OSBPL10 expression is very low in the acute phase, increases significantly at the end of the acute phase, and decreases again in convalescence. For both genes, results in Cuban patients showing warning signs were similar to the ones observed in the totality of patients. These results show that both gene expressions are altered along the dengue disease progression.

We further checked which pathways could have both genes acting together (in Ingenuity database;, and found that they play a central role in the LXR/RXR activation pathway, related to cholesterol metabolism and cytokine production in macrophages (Fig X and Table S in S1 Text). We performed a gene enrichment pathway analysis in the Thai dengue transcriptome in whole blood as a surrogate of the LXR/RXR interaction pathway in macrophages. Unfortunately, there are no robust transcriptome for hepatocytes, in which the same pathway occurs without the cytokine production. Results for comparisons of DHF and DF versus convalescent and controls (Figs Y-AA in S1 Text) showed that the lipid metabolism set of genes is always significantly upregulated in patients, and the main contributing genes are OSBPL10, LDLR and MSR1, the two last mediating the entrance of LDL (low-density lipoprotein) to the cell. NF-kB expression is always upregulated in the convalescents (significantly in DHF comparison), or, biologically more meaningful, downregulated in patients, with main genes been RXRA and NF-kB. The LXR/RXR activation set of genes is never statistically significant, but the most contributing genes are NR1H3/LXRA, ABCA1, ARG2 and NCOR1 up-regulated in DF, and ABCG1, LPL and RXRA down-regulated in DHF. This analysis reinforces the importance in dengue disease of the enlarged pathway for LXR/RXR activation, including the cholesterol/lipids metabolism and the NF-kB control of cytokines. We demonstrated that the African protective genes OSBPL10 and RXRA, which play central roles in this pathway, are always identified as top differentially expressed genes.

Effect of OSBPL10 knockdown on DENV replication

The two shRNA plasmids used to induce OSBPL10 knockdown in the THP-1 cell line were very efficient, as measured by mRNA expression (Fig 5A). In fact, no significant differences in the OSBPL10 expression were observed among THP1/non-transfected and THP1/mock (mean values of 34.62 and 26.58, respectively; two-tailed t-test p = 0.15). While a noteworthy reduction in OSBPL10 expression levels was observed in THP1sh1/OSBPL10 assay (mean of 11.11; p = 0.00022 and p<0.00001, compared with THP-1/non-transfected and THP1/mock, respectively), and an almost complete non-expression in THP1sh2/OSBPL10 assay (mean of 0.30; p<0.00001 and p<0.00001, compared with THP-1/non-transfected and THP1/mock, respectively).

Fig 5. Functional assay of OSBPL10 knockdown and its effect on DENV-replication

(A) Box plots for the OSBPL10 mRNA expression in the various THP1 cells (non-transfected and transfected with mock, sh1 and sh2 plasmids). The boxes represent the interquartile range, the little square the mean, the line the median and the whiskers are the 5% and 95% quartiles. The *** symbol indicates that the two-tailed t-test p-values for comparisons between THP1sh1/OSBPL10 and THP1/non-transfected or THP1/mock, as well as for THP1sh2/OSBPL10 and THP1/non-transfected or THP1/mock are significant. (B) Viral load (log10 of PFU/mL), measured intracellularly and extracellularly, in the various THP1 cells (non-transfected and transfected with mock, sh1 and sh2 plasmids) when infected by DENV2. The *** symbol indicates that the two-tailed t-test p-values for pairwise comparisons (THP1sh1/OSBPL10 vs. THP1/non-transfected or THP1/mock, THP1sh2/OSBPL10 vs. THP1/non-transfected or THP1/mock) are significant.

DENV2 infection assays in these OSBPL10-knockdown cell lines provides robust evidence that down-modulation of OSBPL10 affects in a direct way DENV replication (Fig 5B). Significant (p<0.00001) viral load reductions were observed intracellularly in both OSBPL10 knockdown cell lines (mean values of 2x107 in THP1/non-transfected, 2x106 in THP1/mock, 2x104 in THP1sh1/OSBPL10 and 2x102 in THP1sh2/OSBPL10), as well as extracellularly (mean values of 2x107, 2x107, 2x103 and 2x102, respectively).


Human populations are structured in three main groups, African, European and Asian. The independent selective pressures acting upon these groups can lead different genes to be selected in adaptation to the same pathogen, and those genes can interact in a common crucial pathway or in different pathways of additive importance to the disease process.

The current study supports the African-ancestry-conferred resistance to DHF, in comparison with European background, concurring with the report in Colombia [11]. It is unlikely that DENV has exerted this selective pressure, since its associated mortality is low and it does not alter reproduction. But yellow fever virus, another African-originated flavivirus, which has a remarkable mortality level (being 6.8 times higher in Caucasians), could have generated protective genetic variants against itself, hepatitis C virus (HCV) and DENV [25]. It has been demonstrated that besides infection-related genes, metabolic genes are also under intense selective pressure, and both can interact as in the case of the low-activity alleles of glucose-6-phosphatase dehydrogenase providing reduced risk to malaria infection [26]. It is known that Africans have a lower atherogenic lipid profile, characterized by low triglyceride (T), total cholesterol, and LDL levels, and high high-density lipoproteins (HDL) levels, when compared to Europeans [27]. Signs of selection were already identified in West Africans for APOL1 and CD36 genes involved in lipid metabolism and probably driven by pathogen resistance [28]. Our evidence adds two new genes to the differential lipid profile between Africans and Europeans, which play a role in infectious resistance. We detected signs of positive selection on the OSBPL10 gene, while balancing selection may have generated additional polymorphisms regulating RXRA expression in Africans.

A direct link between dengue infection progression and lipid profile changes has been made, so that lipids may be used as predictors of clinical outcome [29]: increased T and HDL and decreased LDL were observed in severe dengue. Recent metabolic and lipid profiling in serum samples from dengue cohorts [30, 31] have reinforced these earlier findings, showing that DENV infection causes temporary changes in metabolites involved in acute inflammatory responses, with major perturbed metabolic pathways including fatty acid biosynthesis, fatty acid beta-oxidation, phospholipid catabolism and steroid hormone pathway, and that progression into DSS is associated with certain metabolites (phosphatidylcholines, diacylglycerol, phosphatidic acid, phosphatidylserine, triglycerides, and diacylglycerophosphoglycerol) that may act in endothelial cell homeostasis and vascular barrier function. Definitely, lipids are essential to DENV entrance and replication [32]. Flavivirus RNA synthesis and replication occur on an extended network of modified endoplasmic reticulum (ER) membranes, and then maturation takes place in the ER-Golgi complex [33]. These are the main cellular components where OSBPs play a key role on cholesterol and other sterols homeostasis [34]. Our functional assay clearly shows that knockdown of OSBPL10 expression reduces significantly DENV replication, a direct proof that the lower OSBPL10 expression profile in Africans protects this ancestry against dengue disease. Interestingly, replication of HCV and poliovirus has been shown to be dependent on OSBP in a PI4-kinase dependent manner, but DENV did not, possibly due to its ligand being PI3P and not PI4P [35]. This evidence and our detected African-related signs of association with kinases in Cuba calls for future research to be conducted in this group of enzymes.

If the OSBPL10 gene is involved in signaling and transport of lipids, RXRA plays a role in the second part of the cholesterol homeostasis through the LXR/RXR activation pathway, in hepatocytes and macrophages. When cholesterol is in excess, as occurs in infection, the consequent lowering of its cellular concentration is reached by oxysterol and desmosterol binding to LXR, which forms heterodimers with RXRA in order to control the transcription activation of many genes regulating lipid metabolism. In macrophages, RXRA also regulates the integration of immune functions, thus defining the clinical outcome of dengue infection. Indeed, macrophages are key DENV target cells and also the principal source of pro-inflammatory mediators linked to severe dengue disease. LXR/RXRA heterodimers and sumoylated LXR inhibit the NF-kB transcription factor complex, which per se acts upon inflammatory mediators [36]. But a negative control of LXR/RXRA dimers is exerted by IRF3, which is activated by viruses and bacteria that entered the cell through TLR3 and TLR4 receptors, deregulating the cholesterol control and allowing the action of NF-kB transcription factor. It has been demonstrated that during dengue infection [24] there is down-regulation of RXRA expression in an IRF3-dependent manner in the host cell, to achieve optimal IFN expression. After infection, RXRA expression resumes, suppressing the type I IFN induction. Therefore, RXRA not only maintains the basal type I IFN and modulates the host antiviral response, but also regulates the antiviral inflammatory response.

Remarkably, our results offer a comprehensive explanation for various independent observations made in association with dengue. RXRA forms heterodimers with VDR, previously identified as dengue protective in Vietnamese [37]. The RXRA-VDR heterodimers negatively control the expression of several immune function genes. Also, PLCE1, protective against DSS in Vietnamese children [5], interacts with RXRA in the PPARA/RXRA activation pathway, positively controlling the expression of genes again related with lipid metabolism. Perhaps flavivirus resistance arose in Asians through VDR and PLCE1 selection, while OSBPL10 and RXRA selection provided resistance in Africans, all related with central lipids and cytokines pathways. Even the immune system genes associated with dengue illness, such as TNF-α, IL-10, TGF-β1, FcγRIIa and CD209 [3], can also be related with the RXRA gene in several pathways, as their expression is controlled by dimers formed by RXRA and other nuclear factors.

Even the signals we detected in the kinases or kinase-related genes contribute to integrate our results in the general picture. CAMK1D is associated with chemokine, thrombin signalling and xenobiotic metabolism (through RXRA-CAR dimers), activation of neutrophil cells and apoptosis of erythroleukemia cells; MAPKAPK5, that responds to cellular stress and pro-inflammatory cytokines, and the use of a specific inhibitor of this gene blocked DENV assembly [38]; PIK3AP1 which may interact with OSBPL10, as it is possible that this gene is activated by phosphatidylinositol-3-phosphate (PI3P) [39], and links Toll-like receptor signaling to PI3K activation preventing excessive inflammatory cytokine production; SNRK possibly expressed in the liver secretome; GNA14 activates PLC (detected in the Vietnamese dengue GWAS) protein that generates diacylglycerol which further activates PPARA to forms heterodimers with RXRA, positively controlling the expression of genes related with lipid metabolism;[40] DAB-1 may play a role in PI3K binding.

The genomic and functional confirmation of the protection conferred by OSBPL10, RXRA and related lipid metabolism against dengue illness supported in this study points out potential therapeutic applications. The generation of synthetic ligands of LXR should be pursued [41], given its central role in dimerization with RXRA. The possible PI3P-dependent activation of OSBPL10 could be tested through the various PI3K inhibitors being developed in cancer treatment [42]. In addition, the African protection against DHF through kinases supports pursuing the development of kinase inhibitors as they seem to be able to block DENV assembly [38].

Materials and methods

Samples for GWAS genotyping

Havana is the capital of the country and is located in the West with 2 million inhabitants, while Guantanamo city is located in the eastern part with over 200 thousand inhabitants. Case samples from the two cities, collected during the 2006 dengue outbreak and classified according to WHO [43], were included: 67 subjects from Havana with confirmed dengue infection by DENV 4, 36 clinically classified as DF and 31 as DHF; and 70 subjects from Guantanamo with confirmed dengue infection by DENV 3, 41 classified as DF and 29 cases as DHF. Dengue infection was confirmed by dengue IgM detection in serum collected at day 6 of fever onset, as well as virus isolation in Aedes albopictus cell line and RT-PCR in samples collected in the first four days of fever [44, 45].

A screening for identifying dengue asymptomatic cases was conducted during the peak of the 2006 outbreak. Healthy adult individuals, without any dengue clinical symptoms, relatives or neighbours of dengue confirmed patients from three neighbourhood blocks with a high dengue incidence, were daily visited and checked for clinical dengue symptoms over 15 days. The ones that remained symptom free and were PCR or IgM positive were considered as asymptomatic cases. Thirty two asymptomatic individuals from Havana and 16 from Guantanamo, who were unrelated to the patients included in the genotyping, were added. Forty seven samples from healthy blood donors from Havana and 42 from Guantanamo were included as population controls.

Havana groups are referred as HH (dengue haemorrhagic fever cases), HF (dengue fever cases), HA (individuals with asymptomatic infection) and HC (controls). Similarly, GH, GF, GA and GC codes were used for the Guantanamo groups.

Ethics statement

The study was conducted according to the Helsinki Declaration as a statement of ethical principles for medical research involving human subjects [46] and was approved by the Institutional Ethical Review Committee of the Institute of Tropical Medicine Pedro Kourí (IPK) and by the Ethical Committee of the Cuban National Academy of Sciences. Written informed consent was obtained from all individuals.

GWAS genotyping and data quality control

Genotyping was performed for the Illumina Human Omni 2·5 chip and calls were obtained on the Illumina IScan Microarray System by using the Genome Studio software. Quality control was performed in PLINK [47], and SNPs with more than 5% missing genotypes, minor allele frequency (MAF) below 1%, and Hardy-Weinberg equilibrium deviation p-values of less than 0.001 were filtered out. All samples were checked for missingness (threshold of 1·93%), outliers in principal-component analysis (PCA), excess rate of heterozygous loci, and evidence of second-degree relatedness or higher (identity by descent >30%; or identity by state >90%). All studied samples passed these criteria. SNPs located in X and Y chromosomes and in mitochondrial DNA were removed, leading to a final account of 1,922,396 autosomal SNPs.

Global ancestry in Cuba and its influence in dengue infection outcome

Cuban samples were merged with populations from Europe, Africa, Latin America and East Asia (Table A in S1 Text), so that the total final dataset contained 389,574 common SNPs. Ancestry components (K, from 2 to 10) were evaluated in all Cuban groups using the program ADMIXTURE [48], after pruning SNPs for pairwise linkage disequilibrium (r2 > 0·4 in 50-SNP windows), ending up with a total of 77,782 SNPs. The optimal K was estimated through cross-validation of the logistic regression. Two-tailed Wilcoxon rank-sum tests were applied to assess the significance between ancestry proportions in the Cuban groups.

Fine-matched population structure correction and association analysis

Global admixture information was used for fine-matched correction for population structure. Comparison groups were organized by matching paired individuals who did not differ by more than 2% in the African ancestry. Havana and Guantanamo individuals were included together, but as far as possible the comparison pair was from the same city, and asymptomatic infected individuals were considered first than controls as individuals with no dengue disease symptoms. The groups consisted in: 54 asymptomatic/control versus DHF pairs (haemorrhagic comparison group—HCG); 74 asymptomatic/control versus DF pairs (fever comparison group—FCG); 111 asymptomatic/control versus DHF and DF pairs (overall comparison group–OCG). Single-locus allelic association analyses were carried out in PLINK [47] through the χ2 statistics. P-values were displayed as–log10 in Manhattan plots, obtained in HaploView.

Admixture mapping

Local ancestry analysis was performed through RFMix algorithm [49]. 50 Southern European (Italian) and 50 Yoruban samples from the 1000 Genomes database [50] represented the parental European and African components, respectively. These samples were phased together with the Cuban samples in SHAPEIT [51] with the fine scale HapMap phase II genetic map. A test in chromosome 22 was performed with the Spanish sample from 1000 Genomes database replacing the Italian to confirm that results were identical. The difference in the African proportion between asymptomatic/controls and cases was calculated for every position along each chromosome in the Cuban comparison groups (HCG, FCG and OCG), and genomic regions significantly enriched for the African ancestry in asymptomatic/controls were considered as being outside the range defined by the genome mean + 3SD.

Gene expression analysis in patients with dengue illness

A group of 20 patients with suspected dengue acute illness (clinical diagnosis was made by an experienced physician in dengue illness) were recruited at the Salvador Allende Hospital, Havana in 2014. Dengue infection was confirmed as described above. General signs and symptoms as well as warning signs (clinical fluid accumulation, mucosal bleeding, restlessness, severe abdominal pain, persistent vomiting as well as thrombocytopenia<100 platelets x 109/L, and 20% or higher increase of haemo-concentration indicated by haematocrit or HTC) were recorded daily from recruitment to discharge. Three serial peripheral mononuclear cell (PBMC) samples were collected during hospitalization, at days 3, 7 and 30, after symptoms onset.

DNase-treated total RNA was isolated from PBMC using the RNeasy Mini kit (Qiagen, Hilden, Germany) and evaluated by using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). Expression levels of OSBPL10, RXRA and β-actin (housekeeping) genes were determined by RT-PCR (LightCycler 2.0 instrument, Roche), using LightCycler RNA Master SYBR Green I kit (Roche) and designed primers (Table B in S1 Text). Each sample was duplicated and the mean Ct values were normalized to an average Ct value of the housekeeping gene. The assay specificity was evaluated by melting curve analysis. Statistical analysis was performed using the non-parametric Wilcoxon-Mann-Whitney U mean rank test for quantitative variables.

mRNA expression in other datasets, potential functional role and positive selection

Expression of significant genes and genotypes was checked also in public datasets: 1) 465 RNASeq performed in European and African lymphoblastoid cell lines by the 1000 Genomes project [21], expressed in reads per kilobase of exon per million reads mapped (RPKM) and extracted from ArrayExpress (E-GEUV-1); 2) Thai whole blood transcriptome (GDS5093) [22] from nine healthy controls, 28 samples collected between days 2 and 9 after onset of symptoms (acute illness) from secondarily infected patients (18 DF and 10 DHF), and 19 samples collected at convalescence, four weeks or later after discharge. GSEA software [52] was used for gene set enrichment analysis of the LXR/RXR activation pathway in the Thai dengue dataset [22] by considering three sets of genes: lipid metabolism, LXR/RXR activation and NF-kB activation.

Haplotter database ( was used to explore recent positive selection through iHS measure (detects selective sweeps at 50–80% frequencies). By using the selscan package [53], another measure of positive selection (XP-EHH—detects selective sweeps above 80% frequency) was applied to the Cuban HCG.

The significant SNPs were ascertained for location in regulatory regions by using EPDNew [54] and HaploReg [55] tools. EDPNew comprises organism-specific (we obviously used H. sapiens) transcription start site (TSS) collections automatically assembled from carefully selected mass sequences for genome annotation data. HaploReg annotates non-coding diversity by using LD information from the 1000 Genomes Project that allows one to visualize linked SNPs and small indels along with their predicted chromatin state, conservation across mammals and their effect on regulatory motifs.

Cell culture, construction of plasmids and generation of OSBPL10 stable knockdown and mock cell lines

Two OSBPL10 short hairpin RNAs (shRNA; TRCN0000147511 and TRCN0000149806 from Sigma Aldrich, St. Louis, MO USA) were cloned in the mammalian expression vector pcDNA3. These shRNAs were previously reported to induce 80–90% reduction of the OSBPL10 protein [56]. The plasmids and the control/mock plasmid were transformed into E. coli competent cells and the positive recombinant colonies were selected and amplified. The extracted recombinant plasmids were digested, subjected to DNA sequencing and purified by QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany), following the recommended procedure.

THP-1 cells obtained from American Type Culture Collection (ATCC, Rockville, MD USA) were cultured in complete grow medium RPMI1640 supplemented with 10% fetal bovine serum (FBS), L-glutamine and 0.1 mM MEM non-essential amino acids solution (Thermo Fisher Scientific, Waltham, MA USA) at 37°C with 5%CO2. Transfection of the two shRNA and mock plasmids into THP-1 cells was done by using Lipofectamine LTX Reagent (Thermo Fisher Scientific, Waltham, MA USA) and the recombinant cells (THP1sh1/OSBPL10, THP1sh2/OSBPL10, THP1/mock) were selected for Neomicin resistance.

Dengue virus preparation and infection of THP-1 cells

C6/36 cell lines from A. albopictus were grown to confluence, infected at a multiplicity of infection of 0.1 particle forming units (PFU) per cell with the dengue strain DENV-2 A15 Cuba 1981 and cultured in minimum essential medium (MEM) supplemented with 2% fetal calf serum. When a cytopathic effect higher than 50% was noted, culture supernatant was clarified by centrifugation at 10,000 rpm for 30 min at 4 °C. BHK21, clone 15 cell line was used for virus titration as previously described [57]. DENV-2 A15 Cuba titer was of 2x106 PFU/ml. Absence of lipopolysaccharide contamination in the viral preparations was confirmed by the Limulus Amebocyte Lysate test (Bio- Whittaker Inc., Walkersville, MD USA).

THP-1 cells were infected with dengue virus at a multiplicity of infection (MOI) of 0.1. The virus inoculum at a 70–90% confluence was incubated in serum-free medium at 37°C for 1h. The unadsorbed viruses were removed by washing the cells three times with plain medium. The dengue-virus-infected and non-infected cells were replenished with fresh complete medium and incubated for another 72 hours.

OSBPL10 mRNA expression analysis and dengue viral load measurement by qRT-PCR

DNase-treated total RNA was isolated from all THP-1 cell variants by means of RNeasy Mini kit (Qiagen, Hilden, Germany) and evaluated by using the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). The cDNA was synthesized from mRNA with poly(dT) primers and Superscript II reverse transcriptase (Life Technologies, Rockville, MD, USA) and quantified by real-time PCR analysis using the ABI Prism 7700 sequence detection system (Applied Biosystems, Foster City, CA, USA). Samples were analyzed in triplicates for the expression of OSBPL10, as well as for the housekeeping gene β-actin. And each experience was repeated three times (nine values for each condition). Specific expression was calculated in relation to that of β-actin, by using the delta/delta Ct method as recommended by ABI.

RNA from 140 μl of OSBPL10 silenced cell line control THP-1 supernatant or cell culture lysate was extracted, using the QIAamp viral RNA extraction kit (Qiagen, Hilden, Germany) and amplified with TaqMan Assay. Standard curves were obtained with titrated DENV-2 supernatants serially diluted from 106 to 10 PFU/mL. The standard curve obtained by serial dilution of titrated DENV-2 supernatants had a -3.4 slope, the amplification efficiency was of 92.2% and the detection limit was estimated at 10 PFU equivalents/mL. We performed quantitative RT-PCR analyses of viral mRNA isolated from cellular extracts (intracellular) and culture supernatants (extracellular). Intracellular RNA levels indicate viral replication, whereas extracellular viral RNA is a measure of released viral particles in the culture supernatant.

Supporting information

S1 Text. Supporting information containing 27 figures and 19 tables.



We dedicate this paper to the memory of Professor Gustavo Kourí. We thank all the Cuban individuals from Havana and Guantanamo cities who agreed to participate in this study. The authors express thanks to Dr Torreblanca from the Centre of Hygiene and Epidemiology of Guantanamo City, to Dr. Raiza Martinez from the Salvador Allende Hospital, and to Dr. Rosa Martinez and technicians Barbara Marrero and Jose Rodriguez from the Pedro Kourí Tropical Medicine Institute, for their support in the samples collection. The authors also thank the technician Laure Lemée, from the Eukaryote Genotyping Platform Institut Pasteur, for her helpful support with the genotyping. Thanks also to Dr. Daniel Limonta for his helpful reviewing of this paper.

Author Contributions

  1. Conceptualization: BS AS LP MGG.
  2. Data curation: BS PT PS MO BC BR DCS LP.
  3. Formal analysis: PT PS MO BC DCS LP.
  4. Funding acquisition: BS AS LP MGG.
  5. Investigation: BS GG ABP EA BR MA DR.
  6. Methodology: BS PS DCS LP.
  7. Project administration: BS LP.
  9. Software: PT PS MO BC DCS LP.
  10. Supervision: BS AS LP MGG.
  11. Validation: BS LP.
  12. Visualization: BS PT BC MO.
  13. Writing – original draft: BS LP.
  14. Writing – review & editing: BS PT PS GG ABP EA MO BC BR MA DR DCS AS LP MGG.


  1. 1. Guzman MG, Harris E. Dengue. Lancet (London, England). 2015;385(9966):453–65. Epub 2014/09/19.
  2. 2. Ross TM. Dengue virus. Clinics in laboratory medicine. 2010;30(1):149–60. Epub 2010/06/02. pmid:20513545
  3. 3. Coffey LL, Mertens E, Brehin AC, Fernandez-Garcia MD, Amara A, Despres P, et al. Human genetic determinants of dengue virus susceptibility. Microbes Infect. 2009;11(2):143–56. Epub 2009/01/06. pmid:19121645
  4. 4. Garcia G, del Puerto F, Perez AB, Sierra B, Aguirre E, Kikuchi M, et al. Association of MICA and MICB alleles with symptomatic dengue infection. Human immunology. 2011;72(10):904–7. Epub 2011/07/19. pmid:21762746
  5. 5. Khor CC, Chau TN, Pang J, Davila S, Long HT, Ong RT, et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet. 2011;43(11):1139–41. Epub 2011/10/18. PubMed Central PMCID: PMCPmc3223402. pmid:22001756
  6. 6. de la Sierra B, Kouri G, Guzman MG. Race: a risk factor for dengue hemorrhagic fever. Archives of virology. 2007;152(3):533–42. Epub 2006/11/16. pmid:17106622
  7. 7. Agramonte A. Notas clinicas sobre una epidemian reciente de dengue. Rev Med Cirug Cub. 1906;January:222–6.
  8. 8. Guzman MG, Kouri G, Bravo J, Soler M, Morier L, Vazquez S, et al. [Dengue in Cuba: history of an epidemic]. Revista cubana de medicina tropical. 1988;40(2):29–49. Epub 1988/05/01. pmid:3067278
  9. 9. Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. The American journal of tropical medicine and hygiene. 2001;65(3):180–3. Epub 2001/09/20. pmid:11561700
  10. 10. Jaenisch T, Junghanss T, Wills B, Brady OJ, Eckerle I, Farlow A, et al. Dengue expansion in Africa-not recognized or not happening? Emerg Infect Dis. 2014;20(10). Epub 2014/10/02. PubMed Central PMCID: PMC4193177.
  11. 11. Chacon-Duque JC, Adhikari K, Avendano E, Campo O, Ramirez R, Rojas W, et al. African genetic ancestry is associated with a protective effect on Dengue severity in colombian populations. Infect Genet Evol. 2014;27:89–95. Epub 2014/07/16. pmid:25017656
  12. 12. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904–9. Epub 2006/07/25. pmid:16862161
  13. 13. Winkler CA, Nelson GW, Smith MW. Admixture mapping comes of age. Annu Rev Genomics Hum Genet. 2010;11:65–89. Epub 2010/07/03. pmid:20594047
  14. 14. Patterson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, Oksenberg JR, et al. Methods for high-density admixture mapping of disease genes. Am J Hum Genet. 2004;74(5):979–1000. Epub 2004/04/17. PubMed Central PMCID: PMC1181990. pmid:15088269
  15. 15. Galanter JM, Gignoux CR, Torgerson DG, Roth LA, Eng C, Oh SS, et al. Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans study. J Allergy Clin Immunol. 2014;134(2):295–305. Epub 2014/01/11. PubMed Central PMCID: PMC4085159. pmid:24406073
  16. 16. Jeff JM, Armstrong LL, Ritchie MD, Denny JC, Kho AN, Basford MA, et al. Admixture mapping and subsequent fine-mapping suggests a biologically relevant and novel association on chromosome 11 for type 2 diabetes in African Americans. PLoS One. 2014;9(3):e86931. Epub 2014/03/07. PubMed Central PMCID: PMC3940426. pmid:24595071
  17. 17. Guerra R. Manual de Historia de Cuba. Desde su descubrimiento hasta 1868. Habana, Cuba: Editorial Nacional de Cuba; 1964. 720 p.
  18. 18. Guzman MG, Kouri G. Dengue in Cuba: research strategy to support dengue control. Lancet (London, England). 2009;374(9702):1660–1. Epub 2009/11/17.
  19. 19. Libel M. Brote de dengue en Cuba, 2006. Enfermedades infecciosas emergentes y reemergentes, Región de las Américas, Habana. 2006;Cuba: OPS.
  20. 20. Marcheco-Teruel B, Parra EJ, Fuentes-Smith E, Salas A, Buttenschon HN, Demontis D, et al. Cuba: exploring the history of admixture and the genetic basis of pigmentation using autosomal and uniparental markers. PLoS Genet. 2014;10(7):e1004488. Epub 2014/07/25. PubMed Central PMCID: PMC4109857. pmid:25058410
  21. 21. Lappalainen T, Sammeth M, Friedlander MR, t Hoen PA, Monlong J, Rivas MA, et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature. 2013;501(7468):506–11. Epub 2013/09/17. PubMed Central PMCID: PMC3918453. pmid:24037378
  22. 22. Kwissa M, Nakaya HI, Onlamoon N, Wrammert J, Villinger F, Perng GC, et al. Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation. Cell Host Microbe. 2014;16(1):115–27. Epub 2014/07/02. PubMed Central PMCID: PMC4116428. pmid:24981333
  23. 23. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. Epub 2011/06/28. PubMed Central PMCID: PMCPmc3218848. pmid:21702898
  24. 24. Ma F, Liu SY, Razani B, Arora N, Li B, Kagechika H, et al. Retinoid X receptor alpha attenuates host antiviral response by suppressing type I interferon. Nat Commun. 2014;5:5494. Epub 2014/11/25. PubMed Central PMCID: PMCPmc4380327. pmid:25417649
  25. 25. Blake LE, Garcia-Blanco MA. Human genetic variation and yellow fever mortality during 19th century U.S. epidemics. mBio. 2014;5(3):e01253–14. Epub 2014/06/05. PubMed Central PMCID: PMCPmc4049105. pmid:24895309
  26. 26. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science. 2001;293(5529):455–62. Epub 2001/06/26. pmid:11423617
  27. 27. Goedecke JH, Utzschneider K, Faulenbach MV, Rizzo M, Berneis K, Spinas GA, et al. Ethnic differences in serum lipoproteins and their determinants in South African women. Metabolism: clinical and experimental. 2010;59(9):1341–50. Epub 2010/01/26.
  28. 28. Ferrer-Admetlla A, Liang M, Korneliussen T, Nielsen R. On detecting incomplete soft or hard selective sweeps using haplotype structure. Mol Biol Evol. 2014;31(5):1275–91. Epub 2014/02/21. PubMed Central PMCID: PMCPmc3995338. pmid:24554778
  29. 29. Duran A, Carrero R, Parra B, Gonzalez A, Delgado L, Mosquera J, et al. Association of lipid profile alterations with severe forms of dengue in humans. Archives of virology. 2015;160(7):1687–92. Epub 2015/05/06. pmid:25936955
  30. 30. Cui L, Lee YH, Kumar Y, Xu F, Lu K, Ooi EE, et al. Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS Negl Trop Dis. 2013;7(8):e2373. Epub 2013/08/24. PubMed Central PMCID: PMCPmc3744433. pmid:23967362
  31. 31. Voge NV, Perera R, Mahapatra S, Gresh L, Balmaseda A, Lorono-Pino MA, et al. Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes. PLoS Negl Trop Dis. 2016;10(2):e0004449. Epub 2016/02/26. PubMed Central PMCID: PMCPmc4768770. pmid:26913918
  32. 32. Soto-Acosta R, Mosso C, Cervantes-Salazar M, Puerta-Guardo H, Medina F, Favari L, et al. The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity. Virology. 2013;442(2):132–47. Epub 2013/05/07. pmid:23642566
  33. 33. Apte-Sengupta S, Sirohi D, Kuhn RJ. Coupling of replication and assembly in flaviviruses. Current opinion in virology. 2014;9:134–42. Epub 2014/12/03. PubMed Central PMCID: PMCPmc4268268. pmid:25462445
  34. 34. Du X, Brown AJ, Yang H. Novel mechanisms of intracellular cholesterol transport: oxysterol-binding proteins and membrane contact sites. Current opinion in cell biology. 2015;35:37–42. Epub 2015/05/02. pmid:25932595
  35. 35. Wang H, Perry JW, Lauring AS, Neddermann P, De Francesco R, Tai AW. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking. Gastroenterology. 2014;146(5):1373–85.e1-11. Epub 2014/02/12. PubMed Central PMCID: PMCPmc3992183. pmid:24512803
  36. 36. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nature medicine. 2003;9(2):213–9. Epub 2003/01/14. pmid:12524534
  37. 37. Loke H, Bethell D, Phuong CX, Day N, White N, Farrar J, et al. Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. The American journal of tropical medicine and hygiene. 2002;67(1):102–6. Epub 2002/10/05. pmid:12363051
  38. 38. Anwar A, Hosoya T, Leong KM, Onogi H, Okuno Y, Hiramatsu T, et al. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly. PLoS One. 2011;6(8):e23246. Epub 2011/08/23. PubMed Central PMCID: PMCPmc3157368. pmid:21858043
  39. 39. Fairn GD, McMaster CR. The roles of the human lipid-binding proteins ORP9S and ORP10S in vesicular transport. Biochemistry and cell biology = Biochimie et biologie cellulaire. 2005;83(5):631–6. Epub 2005/10/20. pmid:16234851
  40. 40. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem. 1998;273(27):16710–4. Epub 1998/06/27. pmid:9642225
  41. 41. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. The Journal of clinical investigation. 2006;116(3):607–14. Epub 2006/03/03. PubMed Central PMCID: PMCPmc1386115. pmid:16511593
  42. 42. Anderson JL, Park A, Akiyama R, Tap WD, Denny CT, Federman N. Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas. PLoS One. 2015;10(9):e0133610. Epub 2015/09/25. pmid:26402468
  43. 43. WHO. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization; 1997. 84 p.
  44. 44. Vazquez S, Bravo JR, Perez AB, Guzman MG. [Inhibition ELISA. Its utility for classifying a case of dengue]. Revista cubana de medicina tropical. 1997;49(2):108–12. Epub 1997/01/01. pmid:9685972
  45. 45. Rodriguez Roche R, Alvarez M, Guzman MG, Morier L, Kouri G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. Journal of clinical microbiology. 2000;38(9):3508–10. Epub 2000/09/02. PubMed Central PMCID: PMCPmc87421. pmid:10970418
  46. 46. WMA. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4. Epub 2013/10/22. pmid:24141714
  47. 47. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–75. Epub 2007/08/19. PubMed Central PMCID: PMC1950838. pmid:17701901
  48. 48. Alexander DH, Novembre J, Lange K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res. 2009;19(9):1655–64. Epub 2009/08/04. PubMed Central PMCID: PMC2752134. pmid:19648217
  49. 49. Maples BK, Gravel S, Kenny EE, Bustamante CD. RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference. Am J Hum Genet. 2013;93(2):278–88. Epub 2013/08/06. PubMed Central PMCID: PMC3738819. pmid:23910464
  50. 50. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56–65. Epub 2012/11/07. PubMed Central PMCID: PMC3498066. pmid:23128226
  51. 51. Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of genomes. Nat Methods. 2012;9(2):179–81. Epub 2011/12/06.
  52. 52. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50. Epub 2005/10/04. PubMed Central PMCID: PMCPmc1239896. pmid:16199517
  53. 53. Szpiech ZA, Hernandez RD. selscan: an efficient multithreaded program to perform EHH-based scans for positive selection. Mol Biol Evol. 2014;31(10):2824–7. Epub 2014/07/13. PubMed Central PMCID: PMC4166924. pmid:25015648
  54. 54. Dreos R, Ambrosini G, Cavin Perier R, Bucher P. EPD and EPDnew, high-quality promoter resources in the next-generation sequencing era. Nucleic Acids Res. 2013;41(Database issue):D157–64. Epub 2012/11/30. PubMed Central PMCID: PMCPmc3531148. pmid:23193273
  55. 55. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930–4. Epub 2011/11/09. PubMed Central PMCID: PMCPmc3245002. pmid:22064851
  56. 56. Nissila E, Ohsaki Y, Weber-Boyvat M, Perttila J, Ikonen E, Olkkonen VM. ORP10, a cholesterol binding protein associated with microtubules, regulates apolipoprotein B-100 secretion. Biochim Biophys Acta. 2012;1821(12):1472–84. Epub 2012/08/22. pmid:22906437
  57. 57. Alvarez M, Rodriguez Roche R, Bernardo L, Morier L, Guzman MG. Improved Dengue virus plaque formation on BHK21 and LLCMK2 cells: evaluation of some factors. Dengue Bull. 2005;29:49–57.